Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Combination of Ranibizumab with macular laser for macular edema secondary to branch retinal vein occlusion: one-year results from a randomized controlled double-blind trial

Fig. 1

Mean change in BCVA from baseline to the last visit. In comparison between two groups, general linear model was constructed as well for variance analysis with baseline BCVA adjusted. Mean gains in BCVA from baseline to week 52 were similar between two groups (P = 0.5226). Change in BCVA from baseline to week 52 were normally distributed (P > 0.05 in Shapiro-Wilk tests in both groups). Mean ± SD change in BCVA from baseline to week 52 was 17.9 ± 9.0 letters in IVR group, 18.1 ± 9.9 letters in IVR + Laser group

Back to article page